Screening for volunteers to participate in HIV Vaccine Trials at the Fred Hutchinson Cancer Research Center / University of Washington Vaccine Trials Unit

Research Study Description

The overall aim of our studies is to evaluate vaccines for safety and the ability to stimulate immune responses in participants. The ideal vaccine for global use should demonstrate proven safety in HIV negative volunteers, tolerability, and confer protection against HIV. Our studies seek to find an affordable vaccine with the potential for mass production in order to meet global needs.

Time commitment will vary depending on the study.

Eligibility Criteria

Volunteers must be:

in good general health

HIV negative and at low risk for HIV infection

between 18 to 50 years of age

Both males and females are eligible to participate.

Other eligibility criteria may apply depending on the study.

Exclusions (conditions which would prevent a volunteer from participating in this study)

Persons with 1 or more of the following:

an illness or condition that would affect the immune response or would require medication that affects the immune response

an illness or condition that would prohibit repeated blood draws

an illness or condition in which signs or symptoms could be confused with reactions to vaccine